 |
市场调查报告书
商品编码
1511600
动脉切开术用闭合装置的开发平台 - 开发阶段，市场区隔，地区和国家，法规途径，主要企业(2024年版)Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update |
||||||
价格
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
简介目录
本报告提供动脉切开术用闭合装置的开发中产品调查分析，提供涵括各种处于开发阶段产品的比较分析，及进行中的临床试验等全面性资讯。
目录
第1章 目录
第2章 简介
第3章 开发中的产品
- 动脉切开术用闭合装置 - 开发中产品:各开发阶段
- 动脉切开术用闭合装置 - 开发中产品:各市场区隔
- 动脉切开术用闭合装置 - 开发中产品:各地区
- 动脉切开术用闭合装置 - 开发中产品:各法规途径
- 动脉切开术用闭合装置 - 开发中产品:估计核准日
- 动脉切开术用闭合装置 - 进行中的临床试验
第4章 动脉切开术用闭合装置 - 各公司的正在开发的开发中产品
- 动脉切开术用闭合装置企业 - 开发中产品:各开发阶段
- 动脉切开术用闭合装置 - 开发中产品:各开发阶段
第5章 动脉切开术用闭合装置的企业和产品概要
- Aporo Biomedical, Inc.(暂停中):企业概要
- Aporo Biomedical, Inc.(暂停中):开发中产品和进行中的临床试验概要
- Arterica Inc:企业概要
- Arterica Inc:开发中产品和进行中的临床试验概要
- CardioDex Ltd(暂停中):企业概要
- CardioDex Ltd(暂停中):开发中产品和进行中的临床试验概要
- CaveoMed GmbH:企业概要
- CaveoMed GmbH:开发中产品和进行中的临床试验概要
- CloSys Corp:企业概要
- CloSys Corp:开发中产品和进行中的临床试验概要
- CPC of America Inc:企业概要
- CPC of America Inc:开发中产品和进行中的临床试验概要
- CyndRX LLC:企业概要
- CyndRX LLC:开发中产品和进行中的临床试验概要
- Dextera Surgical Inc:企业概要
- Dextera Surgical Inc:开发中产品和进行中的临床试验概要
- Genesis MedTech International Pvt Ltd:企业概要
- Genesis MedTech International Pvt Ltd:开发中产品和进行中的临床试验概要
- Harvard University:企业概要
- Harvard University:开发中产品和进行中的临床试验概要
- Lepu Medical Technology (北京) Co Ltd:企业概要
- Lepu Medical Technology (北京) Co Ltd:开发中产品和进行中的临床试验概要
- 南京市 SealMed Medical Technology Corp Ltd:企业概要
- 南京市 SealMed Medical Technology Corp Ltd:开发中产品和进行中的临床试验概要
- NewMed Medical Co Ltd:企业概要
- NewMed Medical Co Ltd:开发中产品和进行中的临床试验概要
- ProMed Inc:企业概要
- ProMed Inc:开发中产品和进行中的临床试验概要
- Rex Medical LP:企业概要
- Rex Medical LP:开发中产品和进行中的临床试验概要
- Shanghai HeartCare Medical Technology Co Ltd:企业概要
- Shanghai HeartCare Medical Technology Co Ltd:开发中产品和进行中的临床试验概要
- Spiorad Medical Ltd:企业概要
- Spiorad Medical Ltd:开发中产品和进行中的临床试验概要
- Terumo Interventional Systems:企业概要
- Terumo Interventional Systems:开发中产品和进行中的临床试验概要
- University of Rochester:企业概要
- University of Rochester:开发中产品和进行中的临床试验概要
- Vascular Closure Systems Inc:企业概要
- Vascular Closure Systems Inc:开发中产品和进行中的临床试验概要
- Vivasure Medical Ltd.:企业概要
- Vivasure Medical Ltd.:开发中产品和进行中的临床试验概要
- Zylox-Tonbridge Medical Technology Co Ltd:企业概要
- Zylox-Tonbridge Medical Technology Co Ltd:开发中产品和进行中的临床试验概要
第6章 动脉切开术用闭合装置 - 近几年的发展
- 2024 年 4 月 15 日：Vivasure Medical 宣布首例下腔静脉患者接受 PerQseal Elite 血管闭合系统治疗
- 2023 年 12 月 12 日：Vivasure Medical 宣布首位患者接受 PerQseal Elite 闭合装置系统治疗
- 2023 年 11 月 17 日：泰利福在 MANTA 设备试验中招募了第一位患者
- 2023 年 11 月 14 日：Vivasure Medical 宣布第 100 名患者参加了美国重大研究
- 2023 年 8 月 29 日：Haemonetics 宣布在欧洲推出 VASCADE 血管闭合系统
第7章 附录
简介目录
Product Code: GDME1760EPD
GlobalData's Medical Devices sector report, "Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Arteriotomy Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Arteriotomy closure devices are used to achieve the hemostasis of an arterial puncture site after an angiography procedure, percutaneous coronary intervention or a peripheral intervention. Arteriotomy closure devices are used to decrease vascular complications and reduce the time to hemostasis and ambulation compared to the traditional methods such as manual or mechanical compression.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Arteriotomy Closure Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Arteriotomy Closure Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Arteriotomy Closure Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 Arteriotomy Closure Devices Overview
3 Products under Development
- 3.1 Arteriotomy Closure Devices - Pipeline Products by Stage of Development
- 3.2 Arteriotomy Closure Devices - Pipeline Products by Segment
- 3.3 Arteriotomy Closure Devices - Pipeline Products by Territory
- 3.4 Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
- 3.5 Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
- 3.6 Arteriotomy Closure Devices - Ongoing Clinical Trials
4 Arteriotomy Closure Devices - Pipeline Products under Development by Companies
- 4.1 Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development
- 4.2 Arteriotomy Closure Devices - Pipeline Products by Stage of Development
5 Arteriotomy Closure Devices Companies and Product Overview
- 5.1 Aporo Biomedical, Inc. (Inactive) Company Overview
- 5.1.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.2 Arterica Inc Company Overview
- 5.2.1 Arterica Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.3 CardioDex Ltd (Inactive) Company Overview
- 5.3.1 CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.4 CaveoMed GmbH Company Overview
- 5.4.1 CaveoMed GmbH Pipeline Products & Ongoing Clinical Trials Overview
- 5.5 CloSys Corp Company Overview
- 5.5.1 CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview
- 5.6 CPC of America Inc Company Overview
- 5.6.1 CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.7 CyndRX LLC Company Overview
- 5.7.1 CyndRX LLC Pipeline Products & Ongoing Clinical Trials Overview
- 5.8 Dextera Surgical Inc Company Overview
- 5.8.1 Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.9 Genesis MedTech International Pvt Ltd Company Overview
- 5.9.1 Genesis MedTech International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.10 Harvard University Company Overview
- 5.10.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview
- 5.11 Lepu Medical Technology (Beijing) Co Ltd Company Overview
- 5.11.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.12 Nanjing SealMed Medical Technology Corp Ltd Company Overview
- 5.12.1 Nanjing SealMed Medical Technology Corp Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.13 NewMed Medical Co Ltd Company Overview
- 5.13.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.14 ProMed Inc Company Overview
- 5.14.1 ProMed Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.15 Rex Medical LP Company Overview
- 5.15.1 Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview
- 5.16 Shanghai HeartCare Medical Technology Co Ltd Company Overview
- 5.16.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.17 Spiorad Medical Ltd Company Overview
- 5.17.1 Spiorad Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.18 Terumo Interventional Systems Company Overview
- 5.18.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
- 5.19 University of Rochester Company Overview
- 5.19.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
- 5.20 Vascular Closure Systems Inc Company Overview
- 5.20.1 Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.21 Vivasure Medical Ltd. Company Overview
- 5.21.1 Vivasure Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
- 5.22 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
- 5.22.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Arteriotomy Closure Devices- Recent Developments
- 6.1 Apr 15, 2024: Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System
- 6.2 Dec 12, 2023: Vivasure Medical Announces First Patients Treated with PerQseal Elite Closure Device System
- 6.3 Nov 17, 2023: Teleflex enrols first patient in MANTA device trial
- 6.4 Nov 14, 2023: Vivasure Medical Announces 100th Patient Enrolled in U.S. Pivotal Study
- 6.5 Aug 29, 2023: Haemonetics Announces European Expansion for VASCADE Vascular Closure System
7 Appendix
- 7.1 Methodology
- 7.2 About GlobalData
- 7.3 Contact Us
- 7.4 Disclaimer
